Skip to content

Striae Distensae Treatment Using Deep Skin Abrasion

Stretch Mark Treatment Using Subcutaneous Skin Abrasion

Status
Recruiting
Phases
Unknown
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT07087405
Enrollment
10
Registered
2025-07-28
Start date
2025-10-01
Completion date
2026-12-01
Last updated
2026-05-28

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Striae Distensae

Keywords

Striae Distensae

Brief summary

The goal of this clinical trial is to learn if a device works to treat striae distensae. It will also learn about the safety of the device. The main questions it aims to answer are: 1. Does the device improve the appearance of striae distensae? 2. Does the device cause any problems when treating striae distensae? Researchers will compare the appearance of striae distensae before and after treatment with the device. Participants will: 1. Undergo treatment with the device in the clinic 2. Visit the clinic 1 week, 3 months, and 1 year for checkups and tests

Detailed description

Participants will have the area of striae distensae anesthetized with local anesthetic. A biopsy will be performed and a device will be placed underneath the skin that will abrade the skin. Three months later another biopsy will be performed, photographs will be taken, and participants will fill out surveys to determine the effectiveness of the device to improve the appearance of the striae distensae.

Interventions

DEVICEStriae Distensae Treatment Device

One time deep skin treatment

Sponsors

Boston Children's Hospital
Lead SponsorOTHER

Study design

Allocation
NA
Intervention model
SINGLE_GROUP
Primary purpose
TREATMENT
Masking
NONE

Eligibility

Sex/Gender
ALL
Age
18 Years to 70 Years
Healthy volunteers
No

Inclusion criteria

* Striae distensae

Exclusion criteria

* Smoking * coagulation deficiency

Design outcomes

Primary

MeasureTime frameDescription
Improvement in Striae Distensae AppearanceFrom enrollment to 12 months after treatmentComparison of photographs before and after treatment

Countries

United States

Contacts

CONTACTArin Greene, MD
arin.greene@childrens.harvard.edu16173552306
CONTACTPatrick Smits, PhD
patrick.smits@childrens.harvard.edu6173552306
PRINCIPAL_INVESTIGATORArin Greene, MD

Boston Children's Hospital

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: May 29, 2026